AstraZeneca Plc and Daiichi Sankyo Co.’s cancer drug Enhertu bolstered outcomes for patients with early-stage breast cancer, ...

A brisk walk is a popular and accessible way to get into zone 2 cardio and burn fat, says Sickler. Additionally, walking ...

Researchers in Spain and Argentina have developed a ring-shaped protein nanomaterial that binds to and neutralises SARS-CoV-2 ...

A clinical trial of a “smart bomb” cancer drug known as Trodelvy, an antibody-drug conjugate, has shown that the treatment ..

In a Phase III trial, sacituzumab tirumotecan outperformed chemo in previously treated EGFR-mutant NSCLC patients, results presented at the ESMO Congress show.

The Trop-2 protein is highly expressed in EGFR -mutated NSCLC, and resistance to EGFR TKIs such as osimertinib is associated ...

Daiichi and Merck saw the highest ORR—57.1%—in patients who received the top dose of R-DXd. Yet the drugmakers have opted to ...

R-DXd showed a 50.5% objective response rate in platinum-resistant ovarian cancer, with a 5.6 mg/kg dose deemed optimal for further study. The safety profile was manageable, with 93.5% experiencing ...

Patients with an aggressive form of breast cancer who are not candidates for immune checkpoint inhibitor therapy showed ...

An NC farm and creamery owner explains the benefits of this locally-produced milk and its place in the local food moo-vement.

CStone Pharmaceuticals ("CStone," HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of therapies for oncology, autoimmune/inflammation, and other key ...